Skip to content
HomeLatest newsJohnson & Johnson makes Fortune‘s 2017 Change the World list
A photo of Alex Gorsky and Pat Gorksy with mMitra families in India
Alex Gorsky, Chairman and CEO of Johnson & Johnson, and his wife, Pat Gorsky, visit families who’ve benefited from mMitra Johnson & Johnson

Johnson & Johnson makes Fortune‘s 2017 Change the World list

The company nabs the #9 spot this year for helping to decrease mother and baby mortality rates in India through the mMitra program.

Alex Gorsky, Chairman and CEO of Johnson & Johnson, and his wife, Pat Gorsky, visit families who’ve benefited from mMitra Johnson & Johnson

For the second year in a row, Johnson & Johnson has been nominated to the annual Fortune Change the World list, which spotlights 50 top companies globally that have had a “positive social impact through activities that are part of their core business strategy.”

Johnson & Johnson was recognized for its work with mMitra, an innovative mobile-messaging program that sends vital health information to expectant and new mothers living in low-income urban communities in India.

The company ranks #9 on the list this year—up over 20 spots from its #31 ranking on the 2016 list for its work to help combat tuberculosis.

This latest recognition for Johnson & Johnson comes on the heels of being named a Most Admired Company by Fortune in February, underscoring its reputation as one of the best companies to work for.

How mMitra is making a difference

Johnson & Johnson spearheaded mMitra (short for “mobile friend” in Hindi) in 2014, in partnership with the Mobile Alliance for Maternal Action, ARMMAN, the U.S. Agency for International Development, the United Nations Foundation and BabyCenter®.

Their shared goal: help the roughly 150 mothers and 3,500 children under the age of 5 who die each day in India from pregnancy complications or early childhood disease. Such grim statistics are due, in part, to a lack of accessibility to basic health information.

A study conducted by the Foundation for Research in Health Systems on the communities using mMitra showed an increase in antenatal visits and baby immunization rates, as well as earlier registrations of pregnancies.

Since most women throughout India have access to a mobile phone, the thinking with mMitra was that women could get free calls and texts in their dialect providing expert health and preventative care information tailored to a mom’s stage of pregnancy or a child’s development.

“There were limited models of this type of program, and definitely none at scale,” says Alice Lin Fabiano, Johnson & Johnson’s Director of Global Community Impact. “We were the first in the private sector to do something like this in multiple global locations specifically targeting low-income families.”

The results are certainly heartening.

More than 1 million mothers in India have since participated, and an independent study conducted by the Foundation for Research in Health Systems on the communities using mMitra showed an increase in antenatal visits and baby immunization rates, as well as earlier registrations of pregnancies.

And there’s even more planned for mMitra, which is now available in more than 10 countries, including South Africa, Malawi and Mexico.

“We’re now looking at technology beyond voice and text,” Fabiano says. “Videos and visuals will increase the effectiveness of the message and the sustainability of the program.”

More from Johnson & Johnson

Meet the medical engineer behind the innovative heart pump that revolutionized cardiac health

Drawing on his fascination with airplane technology, Thorsten Siess, Ph.D., came up with an idea that became the Impella heart pump. Now, 25 years since it entered the market, this groundbreaking device has helped more than 330,000 patients recover from heart injuries.

What you need to know about Johnson & Johnson’s 2024 third quarter earnings

Check out this infographic breakdown of the company’s third quarter performance, with highlights from its Innovative Medicine and MedTech businesses.

What is a rheumatic disease?

More than 200 conditions are classified as rheumatic diseases, including rheumatoid arthritis, lupus and Sjögren’s disease. They tend to affect the joints and connective tissues, causing pain and swelling and impacting quality of life. Here’s what a doctor wants you to know about the different types, symptoms and risk factors—and how Johnson & Johnson is innovating new treatments.